More search options
Basket icon
No items
Basket icon

Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Compact case
Case
-
Reference no. 302-063-1
Subject category: Strategy and General Management
Authors: Julian Birkinshaw (London Business School (LBS)); Gordon Murray (London Business School (LBS)); R Tansley (London Business School (LBS))
Published by: London Business School
Published in: 2002
Length: 4 pages
Data source: Published sources
Topics: Technology transfer; Knowledge management; Acquisition
Share a link: https://casecent.re/p/21464
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.

Abstract

This is the second of a two-case series (302-062-1 and 302-063-1). This case describes the decision by the board of Roslin BioMed in 1999 to agree to an acquisition by Geron Corp, and the subsequent integration of the two companies. It ends with the resignation of Simon Best, the CEO of Roslin BioMed, and questions as to what should happen next.
Location:
Edinburgh
Industry:
Bio-technology
Size:
Small-medium
Other setting(s):
2000
Teaching note
-
Reference no. 807-005-8
Subject category: Entrepreneurship
Authors: Tina Claudia Ambos (The University of Edinburgh Business School)
Published by: London Business School
Published in: 2007
Length: 4 pages
Data source: Field research
View full details
Case
-
Reference no. 807-005-1
Subject category: Entrepreneurship
Authors: Tina Claudia Ambos (The University of Edinburgh Business School); Julian Birkinshaw (London Business School (LBS))
Published by: London Business School
Published in: 2007
Length: 8 pages
Data source: Field research
Topics: Technology commercialisation; Science-based venture; Academic entrepreneurship
View full details

About

Abstract

This is the second of a two-case series (302-062-1 and 302-063-1). This case describes the decision by the board of Roslin BioMed in 1999 to agree to an acquisition by Geron Corp, and the subsequent integration of the two companies. It ends with the resignation of Simon Best, the CEO of Roslin BioMed, and questions as to what should happen next.

Settings

Location:
Edinburgh
Industry:
Bio-technology
Size:
Small-medium
Other setting(s):
2000

Related

Teaching note
-
Reference no. 807-005-8
Subject category: Entrepreneurship
Authors: Tina Claudia Ambos (The University of Edinburgh Business School)
Published by: London Business School
Published in: 2007
Length: 4 pages
Data source: Field research
View full details
Case
-
Reference no. 807-005-1
Subject category: Entrepreneurship
Authors: Tina Claudia Ambos (The University of Edinburgh Business School); Julian Birkinshaw (London Business School (LBS))
Published by: London Business School
Published in: 2007
Length: 8 pages
Data source: Field research
Topics: Technology commercialisation; Science-based venture; Academic entrepreneurship
View full details